The NCCN criteria for genetic testing includes any woman with breast cancer of Ashkenazi Jewish descent, due to the established frequency of pathogenic variants in BRCA1 and BRCA2 in this population.17 This evidence concerns the gene BRCA2 and breast carcinoma.